Enfusion Inc’s recent filing unveils that its Director Somers Deirdre acquired Company’s shares for reported $17241.0 on Jan 13 ’25. In the deal valued at $10.53 per share,1,637 shares were bought.
Then, Movchan Oleg sold 2,771 shares, generating $28,070 in total proceeds. Upon selling the shares at $10.13, the Chief Executive Officer now owns 526,702 shares.
Before that, Herring Bradley sold 4,134 shares. Enfusion Inc shares valued at $41,877 were divested by the Chief Financial Officer at a price of $10.13 per share. As a result of the transaction, Herring Bradley now holds 266,369 shares, worth roughly $2.88 million.
A number of analysts have revised their coverage, including Goldman’s analysts, who decreased its forecast for the stock in late February from “a Neutral” to “a Sell”. JP Morgan also remained covering ENFN and has decreased its forecast on January 30, 2024 with a “an Underweight” recommendation from previously “Neutral” rating. UBS started covering the stock on November 07, 2023. It rated ENFN as “a Neutral”.
Price Performance Review of ENFN
On Tuesday, Enfusion Inc [NYSE:ENFN] saw its stock unchanged to $10.81. Over the last five days, the stock has gained 3.84%. Enfusion Inc shares have risen nearly 4.95% since the year began. Nevertheless, the stocks have risen 24.11% over the past one year. While a 52-week high of $11.38 was reached on 01/14/25, a 52-week low of $7.52 was recorded on 01/02/25. SMA at 50 days reached $10.07, while 200 days put it at $9.19.
Levels Of Support And Resistance For ENFN Stock
The 24-hour chart illustrates a support level at 10.73, which if violated will result in even more drops to 10.66. On the upside, there is a resistance level at 10.90. A further resistance level may holdings at 11.00. The Relative Strength Index (RSI) on the 14-day chart is 57.54, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at 0.16, which suggests price will go down in the next trading period. Percent R suggests that price movement has been bullish at 24.74%. Stochastics %K at 55.33% indicates the stock is a holding.
How much short interest is there in Enfusion Inc?
A steep rise in short interest was recorded in Enfusion Inc stocks on 2024-12-31, dropping by -0.26 million shares to a total of 0.56 million shares. Yahoo Finance data shows the prior-month short interest on 2024-11-29 was 0.82 million shares. There was a decline of -47.42%, which implies that there is a negative sentiment for the stock.
The most recent change occurred on April 03, 2023 when Piper Sandler began covering the stock and recommended ‘”a Neutral”‘ rating along with a $11 price target.
